MOTS-c Cost Per Month
· Peptide Q&A
MOTS-c typically costs between $150 and $500 per month depending on your dosing protocol, the provider you use, and whether you obtain it through a telehealth clinic or a compounding pharmacy. Pricing varies widely because MOTS-c is still a research-stage peptide without standardized commercial pricing. Contact provider for current pricing
Understanding the factors that affect cost can help you budget for therapy and avoid overpaying. Below is a breakdown of what drives MOTS-c pricing and how to evaluate the value of what you are getting.
What Determines MOTS-c Price
Dosing Protocol
The biggest factor in monthly cost is how much MOTS-c you use. A common dosing range is 5 mg to 10 mg administered three to five times per week. Someone injecting 10 mg daily will spend significantly more than someone using 5 mg three times per week. Your provider will determine the appropriate dose based on your goals and health status.
Source and Purity
MOTS-c sourced from a licensed US compounding pharmacy with third-party purity testing typically costs more than peptides from unregulated online vendors. The premium reflects quality control, sterility standards, and certificates of analysis (COAs). Choosing a cheaper source without proper testing introduces risk.
Provider Fees
Many telehealth peptide clinics charge a monthly membership or consultation fee on top of the peptide cost itself. These fees can range from $50 to $200 per month and may include lab work, ongoing monitoring, or access to a prescriber for dose adjustments.
Typical Monthly Cost Breakdown
| Cost Component | Estimated Range |
|---|---|
| MOTS-c peptide (vial) | $100 to $350 Contact provider for current pricing |
| Provider/clinic fee | $50 to $200 |
| Supplies (syringes, alcohol swabs) | $10 to $25 |
| Lab work (if included separately) | $0 to $150 |
All-in, expect a monthly total of roughly $150 to $500 for a typical protocol. Some clinics offer bundle pricing or multi-month packages that can reduce the per-month cost.
Is MOTS-c Covered by Insurance?
No. MOTS-c is not FDA-approved and is not covered by health insurance plans. All costs are out-of-pocket. Some clinics accept HSA or FSA cards, so check with your plan administrator if that applies.
How to Get the Best Value
- Ask for COAs: Any reputable provider should share certificates of analysis confirming peptide identity and purity above 98%.
- Compare total costs: Look beyond the vial price. Factor in consultation fees, shipping, and supplies.
- Buy in cycles: If your provider offers multi-vial discounts, purchasing enough for a full cycle upfront can save money.
- Avoid rock-bottom prices: If a price seems too good to be true, the product may be underdosed, contaminated, or mislabeled.
how to choose a peptide provider
Frequently Asked Questions
Why is MOTS-c so expensive compared to other peptides?
MOTS-c is a complex mitochondrial-derived peptide that is more difficult to synthesize than simpler peptides like BPC-157. Its production requires precise manufacturing processes, which drives up cost. Limited commercial availability also keeps prices higher.
Can I reduce my MOTS-c cost by using a lower dose?
Possibly. Some providers start patients at 5 mg three times per week, which uses less product than daily protocols. However, never adjust your dose without your provider's guidance, as underdosing may reduce effectiveness.
Do telehealth peptide clinics charge more than local providers?
Not always. Telehealth clinics often have lower overhead and may pass savings to patients. However, some charge premium membership fees. Compare the total monthly cost, including the peptide, consultation, labs, and shipping, before committing.
Is there a generic version of MOTS-c?
MOTS-c is not a branded pharmaceutical, so the concept of a generic does not apply in the traditional sense. All MOTS-c on the market is produced by compounding pharmacies or research chemical suppliers. Quality and pricing vary by manufacturer.
Will MOTS-c prices come down in the future?
It is possible. As synthesis methods improve and demand increases, production costs may decrease. If MOTS-c eventually receives FDA approval for a specific indication, insurance coverage could also lower out-of-pocket costs for patients.